A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
Clinical trial NCT06239298 · UNKNOWN
Trial details
- NCT number
- NCT06239298
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2026-03-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.